Comparative clinical performance of Alinity m HR HPV, cobas 4800 HPV, and cobas 6800 HPV for cervical cancer screening

ABSTRACT Primary high-risk human papillomavirus (HPV) testing is recommended for cervical cancer screening due to its sensitivity and high negative predictive value. Most of the cervical cancers are caused by HPV16 and HPV18, and their presence has been used to guide patient management. Here, we com...

Full description

Bibliographic Details
Published in:	Microbiology Spectrum
Main Authors:	Shihai Huang, Luciana Girotto Gentil, Colleen Schmidt, Richard Cullum, Yan Zhang, Kevin Nelson, Danijela Lucic, Klara Abravaya
Format:	Article
Language:	English
Published:	American Society for Microbiology 2025-09-01
Subjects:	cervical cancer HPV test primary screening HPV genotyping
Online Access:	https://journals.asm.org/doi/10.1128/spectrum.00589-25

Similar Items

Cobas 4800 HPV detection in cervical samples of Polish women
by: Beata Smolarz, et al.
Published: (2019-06-01)

Comparative performance of cobas 4800 HPV Test and Anyplex II HPV HR for high-risk human papillomavirus detection
by: Luani R. Godoy, et al.
Published: (2025-08-01)

CIN2+ detection of the HPV DNA Array genotyping assay in comparison with the Cobas 4800 HPV test and cytology
by: Aleksandra Pesic, et al.
Published: (2019-07-01)

HPV testing for cervical cancer screening: technical improvement of laboratory logistics and good clinical performance of the cobas 6800 in comparison to the 4800 system
by: Helena Frayle, et al.
Published: (2019-03-01)

Comparison between the Roche Cobas 4800 Human Papillomavirus (HPV), Abbott RealTime High-Risk HPV, Seegene Anyplex II HPV28, and Novel Seegene Allplex HPV28 Assays for High-Risk HPV Detection and Genotyping in Mocked Self-Samples
by: Margo Bell, et al.
Published: (2023-08-01)

Development of high-throughput genotyping method of all 18 HR HPV based on the MALDI-TOF MS platform and compared with the Roche Cobas 4800 HPV assay using clinical specimens
by: Xushan Cai, et al.
Published: (2019-08-01)

High-Risk Human Papillomavirus Detection via Cobas<sup>®</sup> 4800 and REBA HPV-ID<sup>®</sup> Assays
by: Sasiprapa Liewchalermwong, et al.
Published: (2022-12-01)

Clinical validation of the Roche cobas HPV test on the Roche cobas 5800 system for the purpose of cervical screening
by: Nikita Mehta, et al.
Published: (2024-10-01)

Is It Time to Genotype Beyond HPV16 and HPV18 for Cervical Cancer Screening?
by: Brandon Wen Bing Chua, et al.
Published: (2022-05-01)

Clinical Performance of Cobas 6800 for the Detection of High-Risk Human Papillomavirus in Urine Samples
by: Brian Joseph Hajjar, et al.
Published: (2023-06-01)

Multiple Human Papilloma Virus (HPV) Infections Are Associated with HSIL and Persistent HPV Infection Status in Korean Patients
by: Moonsik Kim, et al.
Published: (2021-07-01)

Comparison of the Cobas 4800 HPV Test and the Seeplex HPV4A ACE with the Hybrid Capture 2 Test
by: Eun Young Ki, Hee Eun Kim, Yeong-Jin Choi, Jong-Sup Park, Chang Seok Kang, Ahwon Lee
Published: (2013-01-01)

Prevalence of high-risk human papillomavirus by cobas 4800 HPV test in urban Peru
by: Ricardo Iwasaki, et al.
Published: (2014-09-01)

The Intersection of HPV Epidemiology, Genomics and Mechanistic Studies of HPV-Mediated Carcinogenesis
by: Lisa Mirabello, et al.
Published: (2018-02-01)

Trends in HPV and HPV Vaccine Awareness among Gay and Bisexual Males in the U.S
by: Ikechukwu Chidobem, et al.
Published: (2022-04-01)

Parents’ Knowledge and Attitude towards HPV and HPV Vaccination in Poland
by: Katarzyna Smolarczyk, et al.
Published: (2022-02-01)

Genotype-Specific Distribution of High-Risk Human Papillomavirus (HPV) and Microbial Co-Detections in HPV-Positive Women from Southern Croatia
by: Vanja Kaliterna, et al.
Published: (2025-08-01)

A comparative analysis of cycle threshold (Ct) values from Cobas4800 and AmpFire HPV assay for triage of women with positive hrHPV results
by: Yi Zhang, et al.
Published: (2023-11-01)

Association of provider HPV vaccination training with provider assessment of HPV vaccination status and recommendation of HPV vaccination
by: Ikponmwosa Osaghae, et al.
Published: (2022-11-01)

Comparison of human papillomavirus (HPV) detection in urine and cervical swab samples using the HPV GenoArray Diagnostic assay
by: Pornjarim Nilyanimit, et al.
Published: (2017-10-01)

Medical students’ knowledge of HPV, HPV vaccine, and HPV-associated head and neck cancer
by: Eric Y. Du, et al.
Published: (2022-11-01)

Prevalence of HPV Genotypes among Greek Women in Association with Their Potential to Cause Precancerous Lesions
by: Athanasia Kafasi, et al.
Published: (2024-07-01)

Distribution of HPV types among women with HPV-related diseases and exploration of lineages and variants of HPV 52 and 58 among HPV-infected patients in China: A systematic literature review
by: Meng Wang, et al.
Published: (2024-12-01)

The Distribution and Prevalence of High-Risk HPV Genotypes Other than HPV-16 and HPV-18 among Women Attending Gynecologists’ Offices in Kazakhstan
by: Gulzhanat Aimagambetova, et al.
Published: (2021-08-01)

Frequency and distribution of HPV genotypes in 800 genital samples of Ecuadorian men and women from the city of Guayaquil
by: Gustavo David García Muentes, et al.

HPV infection in cervical and other cancers in Saudi Arabia: implication for prevention and vaccination
by: Ghazi eAlsbeih
Published: (2014-03-01)

The influence of political ideology on awareness of HPV and HPV vaccine among adults in the United States
by: Onyema Greg Chido-Amajuoyi, et al.
Published: (2023-08-01)

A systematic literature review to examine the potential for social media to impact HPV vaccine uptake and awareness, knowledge, and attitudes about HPV and HPV vaccination
by: Rebecca R. Ortiz, et al.
Published: (2019-08-01)

Knowledge of HPV and acceptability of HPV vaccine among women in western China: a cross-sectional survey
by: Junyong He, et al.
Published: (2018-07-01)

Approaching a decade since HPV vaccine licensure: Racial and gender disparities in knowledge and awareness of HPV and HPV vaccine
by: Eric Adjei Boakye, et al.
Published: (2017-11-01)

Effect of vaccination against HPV in the HPV-positive patients not covered by primary prevention on the disappearance of infection
by: Dominik Pruski, et al.
Published: (2025-04-01)

The specifities of the HPV-genital infections in males
by: Mihael Skerlev, et al.
Published: (2010-08-01)

Comprehensive HPV genotyping in Fars, Iran: Molecular epidemiology and implications for prevention
by: Amirreza Radfar, et al.
Published: (2025-06-01)

Factors Associated with HPV Genital Warts: A Self-Reported Cross-Sectional Study among Students and Staff of a Northern University in Nigeria
by: Melvin Omone Ogbolu, et al.
Published: (2024-06-01)

A rare case of condyloma acuminatum caused by HPV73 and HPV33 infection
by: Beilei He, et al.
Published: (2022-08-01)

A study of type-specific HPV natural history and implications for contemporary cervical cancer screening programs
by: Maria Demarco, et al.
Published: (2020-05-01)

Updates on HPV Vaccination
by: Ojone Illah, et al.
Published: (2023-01-01)

Trend of HPV Molecular Epidemiology in the Post-Vaccine Era: A 10-Year Study
by: Yueh Lin, et al.
Published: (2023-09-01)

Cepljenje proti HPV
by: Marjetka Uršič-Vrščaj
Published: (2009-06-01)

High-Risk HPV Detection in Paraffin-Embedded Tissue from Cervical Lesions
by: Micaela Almeida, et al.
Published: (2024-09-01)